CAS 57109-90-7

Clorazepato dipotásico

Descripción:

Clorazepato dipotásico es un derivado de benzodiazepina utilizado principalmente como medicamento ansiolítico y anticonvulsivante. Se caracteriza por su capacidad para potenciar los efectos del neurotransmisor ácido gamma-aminobutírico (GABA) en el receptor GABA-A, lo que conduce a propiedades sedantes, ansiolíticas, relajantes musculares y anticonvulsivantes. La sustancia se administra típicamente en su forma de sal dipotásica, que mejora su solubilidad y biodisponibilidad. Clorazepato dipotásico se prescribe a menudo para el tratamiento de trastornos de ansiedad, síntomas de abstinencia de alcohol y ciertos tipos de convulsiones. Es importante señalar que, al igual que otras benzodiazepinas, puede llevar a dependencia y síntomas de abstinencia tras la interrupción después de un uso prolongado. Los efectos secundarios comunes pueden incluir somnolencia, mareos y deterioro cognitivo. Debido a su potencial de abuso y dependencia, Clorazepato dipotásico se clasifica como una sustancia controlada en muchas jurisdicciones, lo que requiere un monitoreo cuidadoso por parte de los profesionales de la salud durante el tratamiento.

Fórmula: C₁₆H₁₁ClK₂N₂O₄

InChI: InChI=1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;;+1;/p-1

Clave InChI: InChIKey=TVVIGDFTYHGWSG-UHFFFAOYSA-M

SMILES: [K]O.C(O)(=O)C1N=C(C=2C(NC1=O)=CC=C(Cl)C2)C3=CC=CC=C3.[K]

Sinónimos:

• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (1:1)
• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt, compd. with potassium hydroxide (K(OH)) (1:1:1)
• 1H-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, hydroxide, potassium salt (1:1:2)
• 4306Cb
• 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid
• Ab 35616
• Abbott 35616
• Apo-Clorazepate
• Azene
• Belseren
• Bipotassium chlorazepate
• Cb 4306
• Chlorazepate
• Chlorazepate Dipotassium
• Chlorazepate dipotassic
• Clorazepate potassium
• Cm 4306
• Dikalium chlorazepate
• Dipotassium chlorazepate
• Dipotassium clorazepate
• Gen-xene
• Mendon
• Nevracten
• Novo-Clopate
• Nu-Clopate
• Potassium hydroxide (K(OH)), compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1)
• Potassium hydroxide, compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1)
• Tencilan
• Tr 19119
• Transene
• Tranxene
• Tranxilen
• Tranxilene
• Tranxilium
• Tranzene
• [2-Phenyl-2-(2-amino-5-chlorophenyl)-1-azavinyl]malonic acid
• potassium 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylate hydroxypotassium (1:1:1)

Clorazepate.dipotassium.monohydrate

Producto controlado

CAS: 57109-90-7

Forma y color: Neat

Ref: LP-CLR-120-HY-10

Clorazepate Dipotassium

Producto controlado

CAS: 57109-90-7

Applications Anxiolytic. Controlled substance (depressant).
References Cone, E., et al.: J. Pharm. Sci., 73, 243 (1984), Maurer, H., et al.: J. Anal. Toxicol., 25, 237 (2001), Beyer, J., et al.: Ther. Drug Monit., 27, 151 (2005),

Fórmula: C₁₆H₁₀ClN₂O₃·HKO·K

Forma y color: White To Light Yellow

Peso molecular: 408.92

Ref: TR-C587365

Clorazepate Dipotassium (1 mg/ml in Methanol)

Producto controlado

CAS: 57109-90-7

Fórmula: C₁₆H₁₀ClN₂O₃·HKO·K

Forma y color: Colourless

Peso molecular: 408.92

Ref: TR-KIT4162

Clorazepic acid dipotasium salt

Producto controlado

CAS: 57109-90-7

Please enquire for more information about Clorazepic acid dipotasium salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fórmula: C₁₆H₁₁ClK₂N₂O₄

Peso molecular: 408.92 g/mol

Ref: 3D-C-2990

Clorazepic acid dipotasium salt

Producto controlado

CAS: 57109-90-7

Clorazepic acid dipotasium salt is a benzodiazepine with anticonvulsant and anxiolytic activity. It is metabolized to clorazepate, which has a longer half-life than the parent drug. Clorazepic acid dipotasium salt can be administered orally, intravenously, or intramuscularly. The drug is not active when taken orally and must be converted to clorazepate before it can exert its effects. Clorazepic acid dipotasium salt has been shown to have minimal toxicity in humans and animals. This drug has been shown to have a dose-dependent effect on δ receptors and serotonergic activity, but does not affect dopamine receptors or histamine H1 receptors. Clorazepic acid dipotasium salt binds to the benzodiazepine receptor site in the brain and decreases the frequency of seizures by inducing sedation

Fórmula: C₁₆H₁₁ClK₂N₂O₄

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 408.92 g/mol

Ref: 3D-FC20518

DIPOTASSIUM CLORAZEPATE MONOHYDRATE CRS - * PSY

Producto controlado

CAS: 57109-90-7

DIPOTASSIUM CLORAZEPATE MONOHYDRATE CRS - * PSY

Ref: 41-Y0002276

Clorazepate Dipotassium CIV

Producto controlado

CAS: 57109-90-7

Alprazolam(inn), camazepam (inn), chlordiazepoxide (inn), clonazepam (inn), clorazepate & other heterocyclic compounds with nitro atom(s) only

Fórmula: C₁₆H₁₁ClK₂N₂O₄

Forma y color: White Light Yellow Crystalline Powder

Peso molecular: 407.96815

Ref: 45-1140509